43 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Hlatky, Cardiologist in Stanford, CA?
Dr. Mark Hlatky, MD is a Cardiologist, who primarily practices in Stanford, CA. He has been practicing for over 43 years and is board certified. Dr. Hlatky graduated from Perelman School of Medicine at the University of Pennsylvania and completed his residency at Duke Univ Med Ctr, Cardiovascular Diseases; University Med Ctr, Internal Medicine. Dr. Hlatky is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Hlatky’s office at (650) 497-8000.
Where did Dr. Hlatky go to medical school and complete their residency?
Residency: Duke Univ Med Ctr, Cardiovascular Diseases; University Med Ctr, Internal Medicine
Medical School: University of Pa Sch of Med, Philadelphia Pa | Perelman School of Medicine at the University of Pennsylvania
Is Dr. Hlatky board certified as a Cardiologist?
Yes, Dr. Mark Hlatky, MD is board certified by the American Board of Internal Medicine
What languages does Dr. Hlatky speak?
Dr. Hlatky and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Cardiologist like Dr. Hlatky typically treat?
As a Cardiologist, conditions treated by Dr. Mark Hlatky may include:
- Arrhythmia
- Atherosclerosis
- Atrial Fibrillation
- Carotid Stenosis
- Coronary Heart Disease
- Endocarditis
- Heart Attack
- Heart Disease
Please contact Dr. Hlatky's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Cardiologist like Dr. Hlatky typically perform?
As a Cardiologist, procedures performed by Dr. Mark Hlatky may include:
- Absent Pulmonary Valve Repair
- Anomalous Coronary Artery Angiography
- Anticoagulation Management
- Aortic Stenosis Repair
- Aortic Valve Repair / Replacement
- Aortopulmonary Window Repair
- Arterial Doppler
- Balloon Septostomy
Please contact Dr. Hlatky's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Hlatky accept my insurance?
Please contact Dr. Hlatky's office to confirm accepted insurance plans.
Where is Dr. Hlatky's office located?
What hospitals are Dr. Hlatky affiliated with?
Castle Connolly Top Hospital
This doctor is affiliated with a Castle Connolly Top Hospital.
Dr. Hlatky has admitting privileges at the following hospitals:
Recognitions
Publications
Association of Corory CT Angiography or Stress Testing With Subsequent Utilization
, 2011
Cost-Effectiveness of Using High-Sensitivity C-Reactive Protein to Identify Intermediate-
, 2010
Economic Outcomes of Treatment Strategies for Type 2 Diabetes Mellitus
, 2009
Criteria for evaluation of novel markers of cardiovascular risk
, 2009
Corory artery bypass surgery compared with percutaneous corory interventions
, 2009
Statin and beta-blocker therapy and the initial presentation of corory heart disease
, 2006
Cost-effectiveness of implantable cardioverter-defibrillators
, 2005
Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass
, 2004
Cost-effectiveness of a conservative
, 2002
Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy -
, 2002
Variation among hospitals in corory-angiography practices
, 1996
JOB STRAIN AND THE PREVALENCE AND OUTCOME OF CORORY-ARTERY DISEASE
, 1995
THE ROLE OF CORORY ANGIOGRAPHY AND CORORY REVASCULARIZATION BEFORE NONCARDIAC VASCULAR-SURGERY
, 1995
USE OF MEDICAL RESOURCES AND QUALITY-OF
, 1994
A BRIEF SELF-ADMINISTERED QUESTIONIRE TO DETERMINE FUNCTIOL-CAPACITY
, 1989
COMPARISON OF PREDICTIONS BASED ON OBSERVATIOL DATA WITH THE RESULTS OF RANDOMIZED CONTROLLED
, 1988
FACTORS AFFECTING SENSITIVITY AND SPECIFICITY OF EXERCISE ELECTROCARDIOGRAPHY
, 1984
Risk factors for atrial fibrillation and their population burden in postmenopausal women
, 2013
Late diagnosis of abdomil aortic aneurysms substantiates underutilization of abdomil aortic
, 2013
Comparative effectiveness of corory artery bypass grafting
, 2013
Effectiveness of beta-Blockers in Heart Failure With Left Ventricular Systolic Dysfunction
, 2013
Volume, outcome, and policy
, 2013
Effectiveness Is the Key to Cost-Effectiveness
, 2013
Use of Medications for Secondary Prevention After Corory Byp
, 2013
Epidemiologic and Statistical Methods for Comparative Effectiveness Research
, 2013
Does Practice Variation Matter?
Compelling Evidence for Corory-Bypass Surgery in Patients with Diabetes
, 2012
Multivessel Corory Artery Bypass Grafting Versus Percutaneous Corory Intervention in ESRD
, 2012
The Effect of Age on Outcomes of Corory Artery Bypass Surgery
, 2012
Trends in the Incidence of Atrial Fibrillation in Older Patients Initiating Dialysis
, 2012
Impact of the Screening Abdomil Aortic Aneurysms Very Efficiently
, 2012
Future Directions for Cardiovascular Disease Comparative Effectiveness Research Report of a
, 2012
Vascular Surgery Patients Prescribed Preoperative beta
, 2012
Repeat Revascularization Is a Faulty End Point for Clinical Trials
, 2012
Framework for Evaluating Novel Risk Markers
, 2012
Cost-Effectiveness of Transcatheter Aortic Valve Replacement
, 2012
Procedural Complications, Rehospitalizations
, 2012
Physician Procedure Volume and Complications of Cardioverter-Defibrillator Implantation
, 2012
The effect of interl thoracic artery grafts on long
, 2011
The effect of bivalirudin on costs
, 2011
Strengthening the reporting of genetic risk prediction studies (GRIPS): explation and elaboration
, 2011
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explation and elaboration.
, 2011
Racial variation in lipoprotein-associated phospholipase A(2) in older adults
, 2011
Physical Activity in Older Subjects Is Associated With Increased Corory Vasodilation The ADVANCE
, 2011
The Year in Epidemiology, Health Services Research, and Outcomes Research
, 2011
Ankle brachial index screening in asymptomatic older adults
, 2011
Persistent Racial Disparities in Survival After Heart Transplantation
, 2011
What We Can Learn From a Decision Model
, 2011
The Cost-Effectiveness of Rosuvastatin Therapy JUPITER
, 2011
Cost-Effectiveness of Genetic Testing in Family Members of Patients With Long-QT Syndrome
, 2011
Right corory wall cmr in the older asymptomatic advance cohort
, 2010
Lack of Association Between the Trp719Arg Polymorphism in Kinesin-Like Protein-6
, 2010
The Relation Between Hospital Procedure Volume
, 2010
Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young
, 2010
The effect of obesity on quality of life in patients with diabetes and corory artery disease
, 2010
Validation of the Stanford Brief Activity Survey
, 2010
Distribution of Asymmetric Dimethylarginine among 980 Healthy
, 2010
Repeat Corory Revascularization Procedures after Successful Bare-Metal or Drug
, 2010
Vision and Creation of the American Heart Association Pharmaceutical Roundtable Outcomes Research
, 2009
The Dilemma of Incidental Findings on Cardiac Computed Tomography
, 2009
The Confirmatory Trial in Comparative-Effectiveness Research
, 2009
A Randomized Trial of Therapies for Type 2 Diabetes and Corory Artery Disease
, 2009
Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients
, 2009
Evaluating Use of Corory Computed Tomography Angiography in the Emergency Department
, 2009
Insulin resistance independently predicts the progression of corory artery calcification
, 2009
Effect of Race on the Clinical Outcomes
, 2009
The Year in Epidemiology, Health Services Research, and Outcomes Research
, 2009
Characterizing the admixed African ancestry of African Americans
, 2009
Expanding the Orbit of Primary Prevention - Moving beyond JUPITER.
, 2008
Incidental Pulmory Nodules on Cardiac Computed Tomography: Prognosis and Use
, 2008
Isolated Disease of the Proximal Left Anterior Descending Artery Comparing the Effectiveness of
, 2008
Health-related quality of life following corory artery bypass graft surgery in post
, 2008
Susceptibility locus for clinical
, 2008
Stents or surgery? New data on the comparative outcomes of percutaneous corory intervention
, 2008
A near null variant of 12
, 2008
Common polymorphisms of ALOX5 and ALOX5AP and risk of corory artery disease
, 2008
Incidental findings on cardiac multidetector row computed tomography among healthy older adults
, 2008
Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLRI) with CAD
, 2008
Matrix metalloproteise circulating levels, genetic polymorphisms
, 2007
Association of polymorphisms in platelet
, 2007
Do plasma biomarkers of coagulation
, 2007
Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of corory disease
, 2007
Systematic review: The comparative effectiveness of percutaneous corory interventions and corory
, 2007
Circulating chemokines accurately identify individuals with clinically significant atherosclerotic
, 2007
Ethnic differences in corory artery calcium in a healthy cohort aged 60 to 69 years
, 2007
Clinical utility of the Stanford brief activity survey in men
, 2007
Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction
, 2007
Preventing tomorrow's sudden cardiac death today: Part 11
, 2007
Preventing tomorrow's sudden cardiac death today: Part 1
, 2007
The high cost of implantable defibrillators
, 2007
Plasma leptin levels and corory artery calcification in older adults
, 2007
Metabolic syndrome and early-onset corory artery disease - Is the whole greater than its parts?
, 2006
Self-rated health among women with corory disease
, 2006
Cost-effectiveness of corory artery bypass grafts versus percutaneous corory intervention for
, 2006
Validation of a new brief physical activity survey among men and women aged 60-69 years
, 2006
Economic evaluation of altertive strategies to treat patients with diabetes mellitus
, 2006
The value of BNP testing
, 2006
Improvement in quality of life after radiofrequency ablation
, 2006
Cost-effectiveness as an outcome in randomized clinical trials
, 2006
Cost effectiveness of cardiac resynchronization therapy
, 2005
Conducting economic evaluations alongside multitiol clinical trials: Toward a research consensus
, 2005
Evidence-based medicine and policy: The case of the implantable cardioverter defibrillator
, 2005
Health-related quality of life in patients with pulmory arterial hypertension
, 2004
Underuse of evidence-based therapies
, 2004
Evidence-based use of cardiac procedure and devices
, 2004
Cardiovascular screening of athletes
, 2004
Cost-effectiveness of bypass surgery versus stenting in patients with multivessel corory artery
, 2003
Differences in medical care and disease outcomes among black and white women with heart disease
, 2003
Depressive symptoms and health-related quality of life - The heart and soul study
, 2003
Effect of postmenopausal hormone therapy on corory heart dise
What is Dr. Hlatky's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Hlatky's National Provider Identifier (NPI) number is 1710013966.
What common questions do patients ask about Dr. Hlatky?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Hlatky
What is Dr. Mark Hlatky's specialty?
Dr. Hlatky is a Cardiologist near Stanford, CA.
What does a Cardiologist do?
An internist specializing in cardiovascular diseases focuses on the diagnosis and management of complex heart and blood vessel conditions, including heart attacks and life-threatening arrhythmias.
Is Dr. Mark Hlatky affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Hlatky is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Cardiologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Cardiologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Dr. Mark Hlatky accepting new patients in Stanford, CA?
Yes, Dr. Mark Hlatky is accepting new patients at this time.
Does Dr. Mark Hlatky offer online booking?
Please contact Dr. Hlatky's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Dr. Mark Hlatky?
Please contact Dr. Hlatky's office at (650) 497-8000 to schedule an appointment.
Where is Dr. Hlatky's office located?
Dr. Hlatky's office is located in Stanford, CA.
Which board certifications does Dr. Mark Hlatky have?
Dr. Mark Hlatky is certified by the American Board of Internal Medicine.
Other Cardiologist Near Stanford, CA
Cardiologist
Accepting patientsCardiologist
Accepting patientsCardiologist
Accepting patients